Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial

NCT03143569 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Left Sided Heart Failure
Left Ventricular Assist Device
Anticoagulant Therapy
Gastro Intestinal Bleeding
Thrombosis, LVAD
Anti-factor Xa
aPTT
Heparin

Interventions

DEVICE: aPTT guided heparin management
DEVICE: Anti-factor Xa guided heparin management

Sponsor

Washington University School of Medicine